Commercial Sales

Choosing the right supply partner

Purchasing and selling to global pharmaceutical companies means having the knowledge and expertise to interpret complex requirements, ethically source the correct products and the ability to comply with legislation, country to country.

Hennessy Mason specialises in cold chain products, orphan drugs and biosimilars. With our global network, experienced leaders and innovated approach, Hennessy Mason ensures the procurement process effectively achieves the goals of our clients.

Cloud Based Approach

A  customisable cloud based platform used to track the entire process – from initial enquiry to successful delivery – ensures all crucial information is captured in line with Good Distribution Practice.

Biosimilars, Cold Chain and Orphan Drugs

Expertise and experience in procurement, storage and handling of orphan drugs, biosimilars and cold chain pharmaceutical products.

Established Global Network

Our global network is proven to handle the requirements of supplying to the pharmaceutical industry.

$105.2 billion US dollars was made in pharmaceutical global revenue in 2016.

In 2015, total Pharmaceutical R&D expenditure in Europe was €33.6 billion.

Total global pharmaceutical sales in 2016 totaled $967 billion US dollars.

Want to talk?
Please call: +44 (0) 20 3150 1110

Contact form

Follow Us